1 Wall Street Analyst Thinks Eli Lilly Stock Is Going to $892. Is It a Buy?
Just after Eli Lilly posted those numbers, Robyn Karnauskas of Truist Securities revised her fair value estimation of its shares. She now believes they're worth $892 apiece, up from her previous $850. The new target implies 15% upside from the stock's latest closing price as I write this. Karnauskas maintained her buy recommendation on the stock.